EFFECTS OF VERAPAMIL ON INVITRO INTRACELLULAR ACCUMULATION AND RETENTION OF DAUNORUBICIN IN BLAST CELLS FROM PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA
- 1 July 1986
- journal article
- research article
- Vol. 68 (1) , 83-88
Abstract
The effects of verapamil on the intracellular pharmacokinetics of daunorubicin (DNR) in blast cells from the bone marrows of patients with acute nonlymphocytic leukemia (ANLL) were studied to determine whether verapamil was capable of enhancing intracellular accumulation and retention of DNR in ANLL, as has been observed in murine P388 cells resistant to DNR. Seventeen marrows from ANLL patients were studied, 13 of which were from patients who were considered to be clinically refractory to DNR. We took care to include such patients in this study sicne, in the P388 model, verapamil enhancement of DNR uptake is observed only in cells resistant to DNR. Intracellular accumulation of DNR was studied by exposing blast cells to DNR (1 .mu.g/mL) .+-. verapamil (6.6 .mu.mol/L) for up to 4 hours. Following a 2-hour exposure of cells to DNR .+-. verapamil, intracellular retention of DNR was studied by incubating the cells in DNR-free medium for 3 hours. Intracellular DNR/106 cells was quantified by fluorometry. In 12 of 15 patient marrows, verapamil failed to enhance intracellular accumulation of DNR. Three patient marrows had a very small increment in DNR uptake in response to verapamil (.apprx. 14% greater than DNR alone) that was significant (P < .05) by paired t test. Intracellular retention of DNR (t1/2) and the area under the intracellular DNR v time curve (AUC) were studied in 17 patient marrow specimens. No significant alterations in these parameters were observed in response to verapamil. These data indicate either that verapamil did not substantially enhance DNR uptake or retention in blast cells obtained from ANLL patients who are clincially resistant to DNR, or that the frequency of DNR-resistant cells (ie, verapamil-responsive cells) among the blast cells obtained from these patients was too low to influence the population mean of intracellular DNR as measured in these studies.This publication has 15 references indexed in Scilit:
- INCREASED ACCUMULATION OF VINCRISTINE AND ADRIAMYCIN IN DRUG-RESISTANT P388-TUMOR CELLS FOLLOWING INCUBATION WITH CALCIUM-ANTAGONISTS AND CALMODULIN INHIBITORS1982
- OVERCOMING OF VINCRISTINE RESISTANCE IN P388 LEUKEMIA INVIVO AND INVITRO THROUGH ENHANCED CYTO-TOXICITY OF VINCRISTINE AND VINBLASTINE BY VERAPAMIL1981
- CELLULAR PHARMACOLOGY OF 7(R)-O-METHYLNOGAROL - NEW ANTI-CANCER AGENT1979
- MECHANISMS OF RESISTANCE TO DAUNORUBICIN IN EHRLICH ASCITES TUMOR-CELLS1978
- INVIVO CHARACTERISTICS OF RESISTANCE AND CROSS-RESISTANCE OF AN ADRIAMYCIN-RESISTANT SUBLINE OF P388 LEUKEMIA1978
- Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cellsBiochemical Pharmacology, 1978
- Classification of Acute LeukemiaAnnals of Internal Medicine, 1977
- Drug Uptake and Ribonucleotide Profiles of Blast-enriched and Blast-depleted Human Bone Marrow Cell PopulationsBritish Journal of Haematology, 1977
- RANDOMIZED CLINICAL COMPARISON OF DAUNORUBICIN (NSC-82151) ALONE WITH A COMBINATION OF DAUNORUBICIN, CYTOSINE-ARABINOSIDE (NSC-63878), 6-THIOGUANINE (NSC-752), AND PYRIMETHAMINE (NSC-3061) FOR TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA1976
- PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSESThe Journal of Experimental Medicine, 1954